AI assistant
Sending…
Edwards Lifesciences Corp — Director's Dealing 2021
Aug 6, 2021
30042_dirs_2021-08-05_3dec876d-6f79-4eb4-8bae-29c5ee75bb5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-08-05
Reporting Person: Szyman Catherine M. (CVP, Critical Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-05 | Common Stock | G | 344.3865 | $0.0000 | Disposed | 27414.5223 | Direct |
More from Edwards Lifesciences Corp
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 17